Parameter | HR | 95% CI | P-value |
---|---|---|---|
Sex male | 2.18 | 0.86–5.54 | 0.1 |
Age > 61y | 1.49 | 0.81–2.72 | 0.2 |
T-stage > 2 | 2.65 | 1.38–5.09 | 0.003 |
N-stage > 1 | 1.8 | 0.8–4.04 | 0.16 |
UICC-stage > III | 1.7 | 0.72–4.04 | 0.23 |
Chemotherapy none | 0.96 | 0.43–2.16 | 0.92 |
HPV negative | 1.48 | 0.55–4 | 0.44 |
MTVprim | 1.03 | 1–1.05 | 0.022 |
MTVall | 1.04 | 1.02–1.06 | < 0.001 |
TLGprim | 1.001 | 1–1.003 | 0.084 |
TLGall | 1.002 | 1.001–1.004 | < 0.001 |
SUVprim | 1.02 | 0.98–1.06 | 0.33 |
SUVall | 1.03 | 0.99–1.08 | 0.11 |